Timing of first postdischarge follow-up and medication adherence after acute myocardial infarction

JAMA Cardiology

Volumn 1, Issue 2, 2016, Pages 147-155

  Faridi, Kamil F ^a   Peterson, Eric D ^b   McCoy, Lisa A ^b   Thomas, Laine ^b   Enriquez, Jonathan ^c   Wang, Tracy Y ^b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PURINERGIC P2 RECEPTOR ANTAGONIST;

ACUTE HEART INFARCTION; AGED; ARTICLE; COHORT ANALYSIS; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; HOUSEHOLD INCOME; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; MEDICATION COMPLIANCE; PATIENT COMPLIANCE; RETROSPECTIVE STUDY; SECONDARY PREVENTION; UNITED STATES; ACUTE CORONARY SYNDROME; ACUTE DISEASE; HEART INFARCTION; HOSPITAL DISCHARGE; PATIENT TRANSPORT; PROCEDURES; PROGNOSIS; STATISTICS AND NUMERICAL DATA; TIME FACTOR; TREATMENT OUTCOME; TRENDS; VERY ELDERLY;

ACUTE CORONARY SYNDROME; ACUTE DISEASE; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEDICARE PART D; MEDICATION ADHERENCE; MYOCARDIAL INFARCTION; PATIENT DISCHARGE; PATIENT TRANSFER; PROGNOSIS; RETROSPECTIVE STUDIES; SECONDARY PREVENTION; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 85014317208     PISSN: 23806583     EISSN: 23806591     Source Type: Journal    
DOI: 10.1001/jamacardio.2016.0001     Document Type: Article

References (34)

1. Roger VL, Go AS, Lloyd-Jones DM, et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation. 2012; 125(1):188-197.
2. Smith SC Jr, Benjamin EJ, Bonow RO, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association. J Am Coll Cardiol. 2011; 58(23):2432-2446.
3. Ho PM, Spertus JA, Masoudi FA, et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med. 2006; 166(17):1842-1847.
4. Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA. 2007; 297(2): 177-186.
5. Krumholz HM, Merrill AR, Schone EM, et al. Patterns of hospital performance in acute myocardial infarction and heart failure 30-day mortality and readmission. Circ Cardiovasc Qual Outcomes. 2009; 2(5):407-413.
6. Forster AJ, Murff HJ, Peterson JF, Gandhi TK, Bates DW. The incidence and severity of adverse events affecting patients after discharge from the hospital. Ann Intern Med. 2003; 138(3):161-167.
7. Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009; 360(14):1418-1428.
8. Misky GJ, Wald HL, Coleman EA. Post-hospitalization transitions: Examining the effects of timing of primary care provider follow-up. J Hosp Med. 2010; 5(7):392-397.
9. Kripalani S, Theobald CN, Anctil B, Vasilevskis EE. Reducing hospital readmission rates: current strategies and future directions. Annu Rev Med. 2014; 65:471-485.
10. Peterson ED, Roe MT, Rumsfeld JS, et al. A call to ACTION (Acute Coronary Treatment and Intervention Outcomes Network): a national effort to promote timely clinical feedback and support continuous quality improvement for acute myocardial infarction. Circ Cardiovasc Qual Outcomes. 2009; 2(5):491-499.
11. Hammill BG, Hernandez AF, Peterson ED, Fonarow GC, Schulman KA, Curtis LH. Linking inpatient clinical registry data to Medicare claims data using indirect identifiers. Am Heart J. 2009; 157(6):995-1000.
12. Goyal A, de Lemos JA, Peng SA, et al. Association of patient enrollment in Medicare Part D with outcomes after acute myocardial infarction. Circ Cardiovasc Qual Outcomes. 2015; 8(6):567-575.
13. Choudhry NK, Shrank WH, Levin RL, et al. Measuring concurrent adherence to multiple related medications. Am J Manag Care. 2009; 15(7): 457-464.
14. Sattler EL, Lee JS, Perri M III. Medication (re)fill adherence measures derived from pharmacy claims data in older Americans: a review of the literature. Drugs Aging. 2013; 30(6):383-399.
15. D'Hoore W, Sicotte C, Tilquin C. Risk adjustment in outcome assessment: the Charlson comorbidity index. Methods Inf Med. 1993; 32(5):382-387.
16. Krumholz HM, Anderson JL, Bachelder BL, et al.; American College of Cardiology/American Heart Association Task Force on Performance Measures; American Academy of Family Physicians; American College of Emergency Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; Society for Cardiovascular Angiography and Interventions; Society of Hospital Medicine. ACC/AHA 2008 performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to develop performance measures for ST-elevation and non-ST-elevation myocardial infarction): developed in collaboration with the American Academy of Family Physicians and the American College of Emergency Physicians: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, Society for Cardiovascular Angiography and Interventions, and Society of Hospital Medicine. Circulation. 2008; 118(24):2596-2648.
17. Arnold SV, Spertus JA, Masoudi FA, et al. Beyond medication prescription as performance measures: optimal secondary prevention medication dosing after acute myocardial infarction. J Am Coll Cardiol. 2013; 62(19):1791-1801.
18. La Bresh KA, Fonarow GC, Smith SC Jr, et al.; Get With the Guidelines Steering Committee. Improved treatment of hospitalized coronary artery disease patients with the Get With the Guidelines Program. Crit Pathw Cardiol. 2007; 6(3):98-105.
19. Naderi SH, Bestwick JP, Wald DS. Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients. Am J Med. 2012; 125(9):882-7.e1.
20. Choudhry NK, Avorn J, Glynn RJ, et al.; Post-Myocardial Infarction Free Rx Event and Economic Evaluation (MI FREEE) Trial. Full coverage for preventive medications after myocardial infarction. N Engl J Med. 2011; 365(22):2088-2097.
21. Choudhry NK, Setoguchi S, Levin R, Winkelmayer WC, Shrank WH. Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patients. Pharmacoepidemiol Drug Saf. 2008; 17(12):1189-1196.
22. Ho PM, Magid DJ, Shetterly SM, et al. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J. 2008; 155(4): 772-779.
23. Wei L, Wang J, Thompson P, Wong S, Struthers AD, MacDonald TM. Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study. Heart. 2002; 88(3):229-233.
24. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005; 353(5):487-497.
25. McGinnis B, Kauffman Y, Olson KL, Witt DM, Raebel MA. Interventions aimed at improving performance on medication adherence metrics. Int J Clin Pharm. 2014; 36(1):20-25.
26. Hernandez AF, Greiner MA, Fonarow GC, et al. Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. JAMA. 2010; 303(17): 1716-1722.
27. Sharma G, Kuo YF, Freeman JL, Zhang DD, Goodwin JS. Outpatient follow-up visit and 30-day emergency department visit and readmission in patients hospitalized for chronic obstructive pulmonary disease. Arch Intern Med. 2010; 170(18): 1664-1670.
28. Hess CN, Shah BR, Peng SA, Thomas L, Roe MT, Peterson ED. Association of early physician follow-up and 30-day readmission after non-ST-segment-elevation myocardial infarction among older patients. Circulation. 2013; 128(11): 1206-1213.
29. Daugherty SL, Ho PM, Spertus JA, et al. Association of early follow-up after acute myocardial infarction with higher rates of medication use. Arch Intern Med. 2008; 168(5):485-491.
30. Briesacher BA, Gurwitz JH, Soumerai SB. Patients at-risk for cost-related medication nonadherence: a review of the literature. J Gen Intern Med. 2007; 22(6):864-871.
31. Safran DG, Neuman P, Schoen C, et al. Prescription drug coverage and seniors: findings from a 2003 national survey. Health Aff (Millwood). 2005; (suppl web exclusives):W5-152-W5-166.
32. Coleman EA, Smith JD, Frank JC, Min SJ, Parry C, Kramer AM. Preparing patients and caregivers to participate in care delivered across settings: the Care Transitions Intervention. J Am Geriatr Soc. 2004; 52(11):1817-1825.
33. Rogers AM, Ramanath VS, Grzybowski M, et al.; American College of Cardiology Foundation Bethesda, MD. The association between guideline-based treatment instructions at the point of discharge and lower 1-year mortality in Medicare patients after acute myocardial infarction: the American College of Cardiology's Guidelines Applied in Practice (GAP) initiative in Michigan. Am Heart J. 2007; 154(3):461-469.
34. Ho PM, Luther SA, Masoudi FA, et al. Inpatient and follow-up cardiology care and mortality for acute coronary syndrome patients in the Veterans Health Administration. Am Heart J. 2007; 154(3): 489-494.